| Affymax shares plunge on drug safety concerns - The Associated Press |
|
|
The Associated PressBut a subgroup of patients not on dialysis experienced a higher rate of side effects than those taking standard treatments — 21.6 percent versus 17.1 ...* Says anemia drug meets main goal of study ReutersAffymax Shares Plunge On Hematide Study Data Wall Street JournalAffymax and Takeda Announce Phase 3 Trials Meet Primary Endpoints for ... read more |